OVERVIEW

New Frontiers and Technological Advances in Noninvasive Prenatal Screening is organized by CMEducation Resources, LLC.

Release Date: Jun 06, 2017
Expiration Date: Jun 06, 2019

Credit Designation Statement
The University of Massachusetts Medical School designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Course Overview
In this web-based program, physicians will learn how ecent developments in noninvasive prenatal screening have helped to advance the detection of fetal genetic abnormalities.

Conference Objectives
Upon completion of this activity, participants will be able to:
• Outline the evolution of prenatal diagnosis and screening for chromosome abnormalities such as Down syndrome;
• Apply non-invasive prenatal screening (NIPT) using cell-free fetal DNA, and understand how it integrates into the current paradigms for screening and diagnostic testing for aneuploidy;
• Compare the different laboratory techniques used to amplify cell-free DNA; and how the two methods, generally described as the “counting method” and the “SNP (single nucleotide polymorphism)based testing” differ in their clinical application, limitations, and potential advantages;
• Detail the SNP based approach to NIPT, and outline the advantages this technology offers compared to the “counting method”; and, specifically, how the different methodologies—i.e. the counting method versus that focused on SNP technology—impact the reliability, predictive value, and usefulness of the NIPT results;
• Apply current practice guidelines from various professional societies such as ACOG and SMFM regarding the integration of NIPT into clinical practice; including, a clinical roadmap for how, on a practical level, clinicians should utilize NIPT in their practice

Additional details will be posted as soon as they are available.